Pharmaceutical manufacturers of Valproic acid

SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.Since 1989, SCI has satisfied worldwide customers with quality and cost- effective APIs, advanced intermediates, and custom products.Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effective production. We work with pharmaceutical and specialty companies worldwide to develop key intermediates, APIs and custom products. Our facility is FDA,EDQM,PMDA and Taiwan TFDA inspected, designed for multi-purpose, full-scale manufacturing.

Euroapi focuses on revolutionizing active component solutions to sustainably fulfill the demands of clients and patients globally. As a prominent figure in active pharmaceutical ingredients, we possess a comprehensive portfolio of around 200 products, encompassing a wide range of technologies, and are constantly developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO). Our 3,350 employees are driven by the commitment to improving access to essential therapies and promoting health

Harman Finochem Limited is an India-based Pharmaceutical Company catering to its clients across the globe. Established by Mr. Bhupinder Singh Manhas in 1983, our core competencies are in manufacturing and exporting of Active Pharmaceutical Ingredients mainly Metformin HCl, Fenofibrate, Divalproex Sodium, Riboflavin Phosphate Sodium, Glycopyrrolate/Glycopyrronium bromide and more.

CBC offers outsourcing services for a diverse range of active pharmaceutical ingredients (API) and intermediates, and is also involved in the trade of agrochemical compounds. Additionally, CBC is expanding its operations to include manufacturing, utilizing cutting-edge technology and original research in collaboration with partner companies in each sector. With a focus on health, safety, and convenience, the company is actively engaged in Fine Chemicals, Pharmaceuticals, and Agrochemicals. Its services encompass the supply of the aforementioned products from various sources, support for contract manufacturing of advanced intermediates and bulk actives, as well as representation of various named chemicals and pharmaceutical manufacturers.

Biesterfeld Spezialchemie stands as a prominent global distributor of specialty chemical products, pharmaceuticals, and food ingredients. The organization provides comprehensive industry expertise and custom, application-oriented technical guidance across a varied product range focusing on the needs of specific sectors, such as composites and tooling, personal care and hygiene, healthcare, paints and coatings, adhesives, polyurethane, construction, nutrition, nutraceuticals, and electrical, electronic, and energy.

CALYX is an Active Pharmaceutical Ingredient and Intermediate manufacturer successfully inspected by the regulatory agencies of USFDA, EDQM, WHO Geneva and other accreditations for the manufacturing site located at Tarapur, Maharashtra (India).

SEQENS, a prominent Fine Chemical corporation, operates 8 chemical facilities in Europe & North America, providing exceptional services pertaining to process advancement and production from k-labs to ton scale: - Synthesis of Raw Materials in specialized facilities with or without cGMP guidelines. - Tailored Production of Key Intermediates and APIs

Our mission is to utilize scientific knowledge and imaginative thinking to contribute to a more positive global environment. Combining the elegance of artistic expression with the exactness of scientific methodology, we are a diverse international group of intellectuals who collaborate with clients to provide fragrances, flavors, experiences, components, and solutions for the products that the world desires. As a prominent figure in the fields of food, beverages, health, biosciences, and sensory experiences on a worldwide scale, we engage in extensive activities and continuously strive to enhance them. For over a century and three decades, our primary focus has been on discovering the most pioneering approaches to assist in the introduction of products that are beneficial for consumers.

G.L. Pharma specializes in pharmaceutical specialty development, registration, production, and marketing. It is a privately owned business based in Austria with two advanced manufacturing facilities and over 1100 committed staff members. Through its partners and local branches, the company operates in more than 50 nations globally. With a 70-year history, the company's primary therapeutic focus includes Pain Management, Addiction Therapy, Epilepsy, and Depressive Disorders. On the other hand, Gall-Pharma GmbH was established in 1981, and it is involved in the wholesale distribution of prescription drugs, proprietary drugs, and toiletries.

Assurgen pharma strongly holds the belief that, with its expertise and innovative background in the pharmaceutical business, it is well positioned for manufacturing APIs & Intermediates and outsourcing for the global market. The company also engages in custom synthesis and contract manufacturing. Ongoing significant investment ensures a consistent supply of high-quality products and world-class service. Assurgen Pharma is known for being flexible, efficient, cost-effective, and responsive to customers' needs. The primary quality policy is to strive for the highest levels of customer satisfaction, with a focus on manufacturing drugs that meet the highest GMP standards.